José María E. S. M. T.
- Country
- Spain
- Department
- Pneumology
Research Overview
- A Phase 2a Study to Evaluate the Safety and Efficacy of ABBV-142 in Adults with Idiopathic Pulmonary Fibrosis
- Efficacy and Safety of Zenagamtide in Participants with Overweight or Obesity and Obstructive Sleep Apnea Treated with Positive Airway Pressure Therapy
- Efficacy and Safety of NNC0487-0111 in Participants with Overweight or Obesity and Obstructive Sleep Apnoea Not Treated with Positive Airway Pressure
Data & Insights
Has run more than one trial at 416 of 747 partner sites.
Specializations
Respiratory Disease Management
This investigator specializes in treating various respiratory conditions, with particular emphasis on Chronic Obstructive Pulmonary Disease (COPD) and severe asthma. Their research encompasses innovative therapeutic approaches for patients with moderate to severe respiratory conditions.
- COPD treatment optimization
- Asthma management strategies
- Bronchiectasis therapy
Pulmonary Fibrosis Research
The investigator focuses on therapeutic interventions for idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF). Their work includes evaluating treatments aimed at improving lung function and reducing disease progression.
- Progressive Fibrosing Interstitial Lung Diseases
- Cough management in fibrosis
- Long-term disease monitoring
Emerging Therapeutic Areas
Their research extends to novel therapeutic approaches including COVID-19 prevention strategies and refractory chronic cough treatment. The investigator evaluates innovative medications and treatment protocols for complex respiratory conditions.
- Novel antibody treatments
- Chronic cough therapeutics
- COVID-19 prophylaxis
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.